Search Details

Word: breast (lookup in dictionary) (lookup stats)
Dates: all
Sort By: most recent first (reverse)


Usage:

...York City rooftop 38 years ago. "And buried in the sands of the sea, where the tide ebbs and flows twice in every 24 hours--if you should reveal the secrets belonging to the degree of first-degree Mason. The second degree is to have your breast torn open and left prey to the vultures of the air. The third degree..." If he wonders whether anyone really cares what happens when you reveal the secrets of a third-degree Mason, Feingold doesn...

Author: /time Magazine | Title: Endangered Conspirators | 5/25/1998 | See Source »

ESTROGEN ALTERNATIVE Raloxifene, which prevents osteoporosis in postmenopausal women, may also reduce risk factors for heart disease--like high cholesterol levels. It's not as effective as estrogen, but unlike the hormone, it's not linked to breast cancer...

Author: /time Magazine | Title: Health Report: May 25, 1998 | 5/25/1998 | See Source »

Even with the decline of 80s power-dressing, some still see dressing, up as the road to success. In the 90s, as the cost of surgical procedures declines, "dressing" takes on a whole new meaning. Abdominal tucks, breast augmentations and face lifts are now less-expensive options for those convinced that improving their appearance gives them an edge in corporate culture and social life...

Author: By Ronald Y. Koo, CRIMSON STAFF WRITERS | Title: Looking To Get Ahead? | 5/20/1998 | See Source »

Although plastic surgery is still fairly expensive--with rhinoplasty, or nose jobs, going for about $3,000 and breast implants for about $2,500--costs are decreasing. In addition, as some professionals point out, price is commensurate with satisfaction and, given the traditional income increase with age, procedures become more affordable over time...

Author: By Ronald Y. Koo, CRIMSON STAFF WRITERS | Title: Looking To Get Ahead? | 5/20/1998 | See Source »

They get access, that is, if there is enough of the drug to go around, and that's not always the case. Beth Nocera of Medford, Mass., a 41-year-old mother of two, has terminal metastatic breast cancer. Nocera wants to try Herceptin, an anticancer drug now in clinical trials. But Herceptin is expensive, and the manufacturer, Genentech, isn't making much beyond what it needs for testing. It currently gives the extra Herceptin to a limited number of women, chosen at random by a computer, and Nocera's number hasn't come up yet. "My fear," she says...

Author: /time Magazine | Title: Why Do I Have To Wait So Long? | 5/18/1998 | See Source »

Previous | 315 | 316 | 317 | 318 | 319 | 320 | 321 | 322 | 323 | 324 | 325 | 326 | 327 | 328 | 329 | 330 | 331 | 332 | 333 | 334 | 335 | Next